Shutout! The Baseball Writers Association of America fails to elect anyone to the Hall of Fame


It’s possible that this year’s Hall of Fame ballot was the most stacked in the history of the institution.  It contained the all-time home run leader. It contained a seven-time Cy Young award winner who may have been the best pitcher in baseball history since the deadball era. It contained the best hitting catcher of all time. It contained a middle infielder who got to 3,000 hits while flashing superior defense and power. It sported a 609-home run hitter a 583-home run hitter, the second best leadoff hitter in the history of the game and at least five others who, had they been inducted, would not be close to the worst players to make the Hall of Fame.

And none of them got in. Not a one. For the first time since 1996, all candidates on the ballot failed to receive the requisite 75% required for induction.  The leading vote getter was Craig Biggio, who received 68% of the vote. Jack Morris received 67.7%, Jeff Bagwell received 59.6% of the vote, Mike Piazza 57.8% and Tim Raines at 52.2%. No other player received more than 50% of the vote. Roger Clemens received 37.6% of the vote and Barry Bonds received 36.2%. Each of those last two received totals far below even the most pessimistic predictions. The full results can be seen here.

The biggest takeaway from all of this: the Baseball Writers Association of America has, for the first time, unequivocally decided that the use of performance enhancing drugs is a disqualifier for induction to the Hall of Fame. It was suspected that this was the case given Mark McGwire and Rafael Palmeiro falling short in previous years, but there are some reasonable non-PED arguments against those fellows’ candidacies.  Not so with Bonds and Clemens. They were so good and so accomplished that, to paraphrase Bill James, you could cut them in half and have two hall of famers each. Maybe three, actually. Their exclusion is solely because a large portion of the electorate believes that one cannot take steroids and call Cooperstown home.

Which, while understandable, flies in the face of baseball history. There are almost certainly already steroids users in the Hall of Fame. Indeed, Hall of Fame voter and Washington Post columnist Thomas Boswell said on camera, in Ken Burns’ “Tenth Inning” that he witnessed a current Hall of Famer taking steroids during his playing career. Maybe his fellow voters ignored him. Maybe, since that player’s induction, whoever he is, their attitudes have changed. Either way, there is certainly now a historical inconsistency baked into the Hall of Fame.  And in no event can anyone who applauds today’s voting results do so on the basis of the Hall of Fame maintaining its purity, for its purity is pure fantasy.

But just as the BBWAA has now clearly stated that drug users are not wanted in the Hall of Fame, it has apparently likewise erected a near-impossible hurdle for those not associated with PEDs to bound, regardless of their merits.

Craig Biggio had 3,000 hits. Tim Raines was one of the best players of the 1980s. Curt Schilling has three World Series rings, was dominant in the playoffs, and was one of the best pitchers in all of baseball for several years when being a pitcher in baseball was about as hard as it has ever been.  While I disagree that we should keep the PED players out, I at least understand the impulse. What’s the point of keeping out guys like Biggio, Raines and Schilling? What’s the point of the Hall of Fame if no one can get in in a year as talent-rich as this one?

But that’s where we are. Not one of the players on the ballot made it in. The induction ceremony in Cooperstown, New York this summer will honor three men — Hank O’Day, Jacob Ruppert, and Deacon White — who were elected by the Veterans Committee last month.  All three of those men have been dead since the 1930s, so I don’t presume it will be a joyful gathering of family and friends reminiscing about their storied pasts. It’ll be more like a memorial service.

Which is somewhat appropriate given that, with their votes, the current electorate is, in this writer’s view, hastening the Hall of Fame to its doom.

Tigers in discussions with Jordan Zimmermann

Jordan Zimmermann
AP Photo/Alex Brandon

Jon Morosi of FOX Sports reports that the Tigers are in discussions with free agent starter Jordan Zimmermann. His sources have told him that the talks have become “serious”.

Zimmermann, 29, has a career 3.32 ERA across parts of seven seasons in the majors. He finished fifth in National League Cy Young Award balloting in 2014, finishing with a 2.66 ERA and a 182/29 K/BB ratio over 199 2/3 innings.

Among starters who have amassed at least 1,000 innings since 2009, only Cliff Lee, Dan Haren, Madison Bumgarner, and Zack Greinke have compiled a better strikeout-to-walk ratio than Zimmermann’s 4.09. While he doesn’t have the star power of other free agents such as Greinke or David Price, the Tigers would certainly improve their rotation by bringing him on board.

Blue Jays still focused on upgrading their pitching

Marco Estrada
AP Photo/LM Otero

Having already added Jesse Chavez and J.A. Happ to the mix and re-signing Marco Estrada early in the offseason, Blue Jays interim GM Tony LaCava said the team will continue to pursue pitching upgrades, as Sportsnet’s Ben Nicholson-Smith reports. Nicholson-Smith added that LaCava declined to comment on free agent ace David Price. It is believed that the Jays will not pursue Price and other big-name free agent starting pitchers given their November activity.

The Jays re-signed Estrada to a two-year, $26 million deal on November 13, acquired Chavez from the Athletics in exchange for reliever Liam Hendriks on November 20 and signed Happ to a three-year, $36 million deal on Friday.

Nicholson-Smith notes in a column on Sportsnet that the Jays need to address the bullpen in particular. That is especially true after swapping Hendriks, who had a career-best 2.92 ERA out of the Jays’ bullpen in 2015, for a back-end starting pitcher.

Report: Jonathan Papelbon is “untradeable”

Jonathan Papelbon
AP Photo/Jacquelyn Martin

Jon Heyman of CBS Sports spoke to an anonymous baseball executive, who said that Nationals closer Jonathan Papelbon is “untradeable”. The Nationals are hoping to trade both Papelbon and the man he displaced, Drew Storen.

Papelbon has a poor reputation in baseball, particularly after a dugout altercation with superstar outfielder Bryce Harper. Focusing strictly on what he does on the field, Papelbon still gets the job done. The 35-year-old finished the last season with a combined 2.13 ERA, 24 saves, and a 56/12 K/BB ratio over 63 1/3 innings between the Phillies and Nationals.

The Nationals owe Papelbon $11 million for the 2016 season.

Minor league home run king Mike Hessman retires

NEW YORK - JULY 29:  Mike Hessman #19 of the New York Mets bats against the St. Louis Cardinals on July 29, 2010 at Citi Field in the Flushing neighborhood of the Queens borough of New York City. The Mets defeated the Cardinals 4-0.  (Photo by Jim McIsaac/Getty Images)
Jim McIsaac/Getty Images

Baseball America’s J.J. Cooper reports that corner infielder Mike Hessman has retired from professional baseball after 20 seasons. Hessman hit 433 home runs in the minor leagues, an all-time record. He broke Buzz Arlett’s record this past August and with style as #433 was a grand slam.

Hessman, 37, was selected in the 16th round of the 1996 draft by the Braves and remained with the organization through the 2004 season. He then went to the Tigers from 2005-09, the Mets in 2010, then drifted into the Astros and Reds’ farm systems before returning to the Tigers for the last two years.

Hessman took 250 plate appearances at the major league level, batting .188/.272/.422 with 14 home runs and 33 RBI.